Vardenafil (Levitra, BAY38-9456)
Sponsors
Bayer
Conditions
Erectile DysfunctionMetabolic SyndromeProstatic Hypertrophy, BenignSafety
Phase 2
Phase 3
Phase 4
FDA Phase IV - Commitment - Retinal Function Study
CompletedNCT00461565
Start: 2005-02-28End: 2006-10-31Updated: 2015-03-19
Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia
CompletedNCT00668135
Start: 2003-03-31End: 2004-04-30Updated: 2014-12-17
Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome
CompletedNCT00738400
Start: 2008-11-30End: 2009-10-31Updated: 2015-11-16
Unknown Phase
Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice
CompletedNCT01106118
Start: 2010-01-31End: 2013-08-31Updated: 2016-10-17
LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers
CompletedNCT01207947
Start: 2007-10-31End: 2010-03-31Updated: 2015-01-21
Real Life Safety and Efficacy of Vardenafil
TerminatedNCT01215409
Start: 2008-02-29End: 2008-11-30Updated: 2014-05-19